BLADDER ADENOCARCINOMA STAGE UNSPECIFIED

BLADDER ADENOCARCINOMA STAGE UNSPECIFIED was reported 47 times

These drug classes are most commonly taken by patients reporting BLADDER ADENOCARCINOMA STAGE UNSPECIFIED:

# Drug Count
0 Nonsteroidal Anti-inflammatory Drug [EPC] 9
1 Platelet Aggregation Inhibitor [EPC] 9
2 Angiotensin Converting Enzyme Inhibitor [EPC] 5
3 Corticosteroid [EPC] 4
4 HMG-CoA Reductase Inhibitor [EPC] 4
5 Interleukin-6 Receptor Antagonist [EPC] 4
6 Serotonin Reuptake Inhibitor [EPC] 4
7 Sulfonylurea [EPC] 4
8 Calcineurin Inhibitor Immunosuppressant [EPC] 3
9 Proton Pump Inhibitor [EPC] 3
10 Androgen Receptor Inhibitor [EPC] 2
11 Azole Antifungal [EPC] 2
12 CD20-directed Cytolytic Antibody [EPC] 2
13 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2
14 Folate Analog Metabolic Inhibitor [EPC] 2
15 Glinide [EPC] 2
16 Non-Standardized Food Allergenic Extract [EPC] 2
17 Non-Standardized Plant Allergenic Extract [EPC] 2
18 Nucleoside Analog Antiviral [EPC] 2
19 Peroxisome Proliferator Receptor alpha Agonist [EPC] 2
20 5-alpha Reductase Inhibitor [EPC] 1
21 Angiotensin 2 Receptor Blocker [EPC] 1
22 Aromatase Inhibitor [EPC] 1
23 CD52-directed Cytolytic Antibody [EPC] 1
24 Cholinesterase Inhibitor [EPC] 1
25 GLP-1 Receptor Agonist [EPC] 1
26 General Anesthetic [EPC] 1
27 Insulin Analog [EPC] 1
28 Kinase Inhibitor [EPC] 1
29 Loop Diuretic [EPC] 1
30 Microtubule Inhibitor [EPC] 1
31 Nucleoside Metabolic Inhibitor [EPC] 1
32 Peroxisome Proliferator Receptor gamma Agonist [EPC] 1
33 Phosphodiesterase 4 Inhibitor [EPC] 1
34 Platinum-based Drug [EPC] 1
35 Polyene Antifungal [EPC] 1
36 Purine Antimetabolite [EPC] 1
37 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1
38 Thalidomide Analog [EPC] 1
39 Thiazide Diuretic [EPC] 1
40 Thiazolidinedione [EPC] 1
41 Tumor Necrosis Factor Blocker [EPC] 1
42 Typical Antipsychotic [EPC] 1
43 Vascular Endothelial Growth Factor Inhibitor [EPC] 1
44 Vitamin C [EPC] 1
45 mTOR Inhibitor Immunosuppressant [EPC] 1